Alkyl Amines Chemicals Ltd
Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.
- Market Cap ₹ 10,360 Cr.
- Current Price ₹ 2,026
- High / Low ₹ 2,798 / 1,805
- Stock P/E 65.1
- Book Value ₹ 234
- Dividend Yield 0.49 %
- ROCE 27.9 %
- ROE 21.5 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.5%
- Company has been maintaining a healthy dividend payout of 20.8%
Cons
- Stock is trading at 8.67 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
288 | 366 | 446 | 476 | 484 | 501 | 616 | 846 | 993 | 1,242 | 1,542 | 1,682 | 1,496 | |
246 | 308 | 362 | 390 | 393 | 405 | 499 | 682 | 736 | 812 | 1,216 | 1,335 | 1,237 | |
Operating Profit | 42 | 58 | 85 | 87 | 91 | 95 | 118 | 164 | 257 | 430 | 326 | 347 | 259 |
OPM % | 15% | 16% | 19% | 18% | 19% | 19% | 19% | 19% | 26% | 35% | 21% | 21% | 17% |
3 | 1 | 2 | 2 | 2 | 1 | 2 | 4 | 40 | 6 | 14 | 10 | 15 | |
Interest | 12 | 13 | 12 | 10 | 8 | 8 | 8 | 15 | 10 | 6 | 3 | 3 | 5 |
Depreciation | 9 | 10 | 10 | 11 | 13 | 14 | 16 | 23 | 27 | 29 | 35 | 45 | 53 |
Profit before tax | 24 | 36 | 65 | 67 | 72 | 74 | 96 | 130 | 260 | 401 | 302 | 309 | 216 |
Tax % | 28% | 33% | 34% | 32% | 31% | 32% | 33% | 36% | 17% | 26% | 26% | 26% | |
17 | 24 | 43 | 45 | 50 | 50 | 64 | 84 | 215 | 295 | 225 | 229 | 159 | |
EPS in Rs | 3.36 | 4.69 | 8.41 | 8.91 | 9.77 | 9.87 | 12.61 | 16.42 | 42.21 | 57.91 | 44.04 | 44.75 | 31.13 |
Dividend Payout % | 24% | 21% | 19% | 18% | 41% | 20% | 22% | 20% | 19% | 17% | 23% | 22% |
Compounded Sales Growth | |
---|---|
10 Years: | 16% |
5 Years: | 22% |
3 Years: | 19% |
TTM: | -12% |
Compounded Profit Growth | |
---|---|
10 Years: | 25% |
5 Years: | 29% |
3 Years: | 7% |
TTM: | -30% |
Stock Price CAGR | |
---|---|
10 Years: | 42% |
5 Years: | 42% |
3 Years: | -4% |
1 Year: | -14% |
Return on Equity | |
---|---|
10 Years: | 29% |
5 Years: | 30% |
3 Years: | 29% |
Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 79 | 97 | 130 | 165 | 189 | 235 | 287 | 355 | 526 | 782 | 980 | 1,159 | 1,185 |
123 | 146 | 151 | 135 | 111 | 120 | 181 | 165 | 87 | 47 | 23 | 85 | 94 | |
61 | 79 | 98 | 93 | 95 | 147 | 159 | 218 | 160 | 306 | 359 | 336 | 280 | |
Total Liabilities | 273 | 332 | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,590 | 1,568 |
122 | 126 | 155 | 151 | 187 | 220 | 355 | 376 | 423 | 458 | 629 | 719 | 803 | |
CWIP | 6 | 9 | 3 | 31 | 16 | 35 | 18 | 43 | 45 | 138 | 143 | 352 | 333 |
Investments | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 30 | 0 | 0 | 0 |
143 | 195 | 229 | 218 | 201 | 256 | 262 | 328 | 315 | 520 | 600 | 519 | 433 | |
Total Assets | 273 | 332 | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,590 | 1,568 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
36 | 22 | 46 | 61 | 101 | 63 | 102 | 144 | 188 | 364 | 205 | 248 | |
-19 | -27 | -26 | -31 | -35 | -65 | -132 | -67 | -41 | -213 | -206 | -277 | |
-13 | 5 | -13 | -36 | -68 | -2 | 32 | -60 | -135 | -86 | -57 | 8 | |
Net Cash Flow | 4 | 0 | 7 | -6 | -2 | -3 | 2 | 17 | 12 | 65 | -58 | -21 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 77 | 76 | 73 | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 |
Inventory Days | 124 | 141 | 133 | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 |
Days Payable | 63 | 73 | 79 | 58 | 63 | 120 | 78 | 104 | 57 | 133 | 105 | 84 |
Cash Conversion Cycle | 137 | 143 | 128 | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 |
Working Capital Days | 99 | 105 | 96 | 93 | 87 | 84 | 76 | 56 | 54 | 34 | 40 | 46 |
ROCE % | 18% | 21% | 28% | 26% | 26% | 24% | 25% | 29% | 41% | 56% | 33% | 28% |
Documents
Announcements
- Disclosure To Be Made By An Entity Identified As NOT A Large Corporate 18h
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 18h
- Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31, 2024 And Recommendation Of Final Dividend, If Any, On The Equity Shares Of The Company For The Financial Year Ended March 31, 2024 15 Apr
- Compliances - Regulation 40 (10) - PCS Certificate 11 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
Concalls
-
Nov 2023TranscriptPPTREC
-
May 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
May 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Jul 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Jun 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Jun 2017TranscriptPPT
-
May 2016TranscriptPPT
Business Leadership
100+ products, most developed inhouse
Global leader in Ethyl amines.
One of the leading players globally in DEHA
One of the largest producers of DMA-HCL
Leading producer of Acetonitrile with a unique process [1]